1. Home
  2. GENI vs NBTX Comparison

GENI vs NBTX Comparison

Compare GENI & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genius Sports Limited

GENI

Genius Sports Limited

HOLD

Current Price

$6.19

Market Cap

1.6B

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$36.10

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GENI
NBTX
Founded
2016
2003
Country
United Kingdom
France
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
GENI
NBTX
Price
$6.19
$36.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
1
Target Price
$12.75
$36.00
AVG Volume (30 Days)
6.4M
53.7K
Earning Date
05-07-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$24.00
$58.17
Revenue Next Year
$20.12
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.83
$4.46
52 Week High
$13.73
$57.14

Technical Indicators

Market Signals
Indicator
GENI
NBTX
Relative Strength Index (RSI) 54.62 45.56
Support Level $5.68 $30.15
Resistance Level $6.75 $41.89
Average True Range (ATR) 0.49 2.49
MACD 0.00 -0.28
Stochastic Oscillator 38.62 48.79

Price Performance

Historical Comparison
GENI
NBTX

About GENI Genius Sports Limited

Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas: Sports Technology and Services; Betting Technology, Content, and Services; and Media Technology, Content, and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content, and Services division. Geographically, the company derives a majority of its revenue from America.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: